Cellular Neurothekeoma of the Upper Lip in an Infant  by Pan, Hsin-Yen et al.
Pediatrics and Neonatology (2014) 55, 71e74Available online at www.sciencedirect.com
journal homepage: http: / /www.pediatr -neonatol .comCASE REPORTCellular Neurothekeoma of the Upper Lip in
an InfantHsin-Yen Pan a, Sheng-Hong Tseng b, Chia-Chi Weng a, Yun Chen a,c,*aDivision of Pediatric Surgery, Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao,
New Taipei City, Taiwan
bDepartment of Surgery, National Taiwan University Hospital and
National Taiwan University College of Medicine, Taipei, Taiwan
cDepartment of Chemical Engineering and Materials Science, Yuan Ze University, Taoyuan, Taiwan
Received Dec 13, 2011; received in revised form Feb 16, 2012; accepted Nov 7, 2012Key Words
cellular
neurothekeoma;
infant;
lip tumor* Corresponding author. Departme
Memorial Hospital, No. 21, Sectio
Banciao, New Taipei 220, Taiwan.
E-mail address: ychen@mail.femh.
1875-9572/$36 Copyright ª 2012, Taiw
http://dx.doi.org/10.1016/j.pedneo.2Cellular neurothekeoma is an uncommon benign skin neoplasm and also a variant of neurothe-
keoma. Cellular neurothekeomas usually occur in the skin of the upper trunk, head, or neck of
children and young adults; however, they rarely occur in infants or involve the lip. A 6-month-
old male infant was incidentally found to have a tumor in the upper lip. The tumor was elastic,
nontender, and movable, and the overlying mucosa and skin were normal without discolor-
ation. The tumor was excised from the mucosal side of the upper lip, and a pathological exam-
ination revealed cellular neurothekeoma. Cellular neurothekeoma in the lip of an infant
without overlying skin discoloration might delay the diagnosis and lead to wrong preoperative
diagnosis. No similar case has been reported in the literature.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Lip tumors in children are uncommon, and most of them are
benign.1,2 The pathology of lip tumors is variable, withnt of Surgery, Far-Eastern
n 2, Nan-Ya South Road,
org.tw (Y. Chen).
an Pediatric Association. Publish
012.12.004hemangioma as the most common one.1,2 Cellular neuro-
thekeoma is an uncommon benign skin neoplasm and
a variant of neurothekeoma.3 Cellular neurothekeomas
usually occur in the skin of the upper trunk, head, or neck
of children and young adults; however, they rarely occur in
infants or involve the lip.3e5 We describe a case of cellular
neurothekeoma in the upper lip of a 6-month-old male
infant. No similar case exists in the literature. The clinical
and pathological characteristics of this patient are dis-
cussed, and the literature is reviewed.ed by Elsevier Taiwan LLC. All rights reserved.
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A 6-month-old previously healthy male infant was found
incidentally to have a nodular lesion in the upper lip by his
mother. On examination, the patient was well except that
a nodule was noted in his upper lip. This nodule was elastic,
nontender, movable, and measured 1.0  0.7  0.5 cm. The
overlying mucosa and skin were normal without discolor-
ation. No neck lymph node enlargement was found. No
other abnormal physical or laboratory findings were
present. The patient had no history of trauma, and the
family history of neoplasm was negative. Ultrasonogram
revealed a well-defined, hypoechoic, heterogeneous mass.
The preoperative diagnosis was an epidermoid cyst. An
operation was performed under general anesthesia. We
approached the tumor from the mucosal side of the upper
lip (Figure 1). The tumor was well-defined, elastic, unen-
capsulated, and extended to the submucosal muscular
layer. The tumor was totally excised. The patient stood the
operation well, and the postoperative course was
uneventful. Histological examination (Figure 2) revealed
that the tumor was composed of hypercellular epithelioid
cells with diffuse and fascicular growth patterns. Large,
hyperchromatic tumor cells and focal mitoses were seenFigure 1 Photographs of the patient. (A) Absence of discol-
oration of the upper lip. (B) The tumor was excised from the
mucosal side of the upper lip.
Figure 2 Histopathology of the tumor. The tumor was
composed of hypercellular epithelioid cells with diffuse and
fascicular growth patterns. [Hematoxylin and eosin staining:
(A) 40; (B) 200.]occasionally. Myxomatous change and some trapped nerve
bundles were identified. No atypia was found. Immunohis-
tochemically, the tumor was positive for neuron-specific
enolase and smooth muscle actin, but negative for S-100
protein, desmin, and glial fibrillary acidic protein. Mild
immunoreactivity of CD34 was noted. The immunoreac-
tivity of NKI/C3 was unclear because no such examination
was done. Histologically, the tumor was a cellular neuro-
thekeoma. After a 6-month follow-up, the patient was well,
and no tumor recurrence was noted.
3. Discussion
Soft tissue tumors in children differ from those in adults
in frequency, anatomical site, histological types, and
prognosis.6 Tumor occurring in the lip of an infant is
extremely rare and difficult to diagnose, especially for
a lesion without changes in the overlying skin, as in this
case. The pathology of lip tumors includes hemangioma,
lymphangioma, hemangiolymphangioma, papilloma,
neurofibroma, retention cyst of small salivary glands,
venous malformation, eosinophilic granuloma, common
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of neuroblastoma, with hemangioma as the most
common.1,2 However, our patient’s tumor was a cellular
neurothekeoma.
Neurothekeoma usually presents a subepithelial Grenz
zone, infiltrative growth pattern, mild nuclear atypia,
lymphohistiocytic infiltrate, hyalinized collagen, giant
cells, and various stroma.7 Traditionally, neurothekeoma is
classified into three types based on cellularity, mucin
content, and growth pattern: hypocellular (myxoid) type,
cellular type, and mixed type, depending on the amount of
myxoid matrix.4,5 Myxoid neurothekeomas have >50%
myxoid matrix, cellular neurothekeomas have &10% myx-
oid matrix, and mixed-type neurothekeomas have >10%
and &50% myxoid matrix.4,5 In myxoid neurothekeomas,
there are well-circumscribed fascicular masses with
a prominent myxoid stroma.5 This type characteristically
produces positive results of stain for S-100, collagen type
IV, and nerve growth factor receptor; it does not stain for
epithelial membrane antigen or markers of histiocytic
differentiation.5 In contrast, cellular neurothekeomas show
no evidence of encapsulation and have a lobular growth
pattern; moreover, the cells are epithelioid with eosino-
philic cytoplasm.5 The tumor cells in the cellular neuro-
thekeomas do not stain with antibody to S-100, collagen
type IV, or nerve growth factor receptor.5 The mixed type
of neurothekeomas usually shows areas of varied cellularity
that contain focal myxoid region and mixed immunohisto-
chemical reactivity.5
The origin of cellular neurothekeomas is uncertain
because they consist of a mixture of undifferentiated cells
with immature features of Schwann cells, fibroblasts,
myofibroblasts, perineural cells, smooth muscle cells, and
histiocytes.8 Recent studies have found that the gene
expression pattern of neurothekeomas of all subtypes,
including cellular neurothekeoma, closely resembles that
of cellular fibrous histiocytomas; thus, neurothekeoma is
considered a variant of fibrous histiocytoma.9 However,
the origin of cellular neurothekeoma is still debatable,
and cellular neurothekeoma is difficult to diagnose
because of its morphologic similarity to other dermal
tumors.5,9 Thus, immunohistochemical studies are often
performed to establish a diagnosis.3,4,9 The present case
was negative for S-100, desmin, and glial fibrillary acidic
protein, and positive for neuron-specific enolase, smooth
muscle actin, and mild immunoreactivity for CD34, which
is consistent with most cellular neurothekeomas described
in the literature.3,4,9 NKI/C3 has been described as
a marker for melanoma, and it has recently been used as
a marker to separate cellular neurothekeoma from other
dermal tumors.10 The cellular neurothekeomas frequently
have a positive immunoreaction for NKI/C3, whereas
myxoid neurothekeomas often show negative NKI/C3
immunoreactivity, which indicates that NKI/C3 immuno-
reactivity may be of value in distinguishing between
cellular and myxoid neurothekeomas.3,11 However, NKI/C3
stains a broad spectrum of neoplastic tissues including
juvenile xanthogranuloma, atypical fibroxanthoma, and
cellular fibrous histiocytoma.10 Thus, this marker seems to
lack specificity, and caution should be exercised when
diagnosing cellular neurothekeomas based solely on posi-
tive staining with NKI/C3.3Neurothekeomas most frequently arise in the dermis or
subcutaneous tissue of the face, neck, shoulders, and arms
of children or young adults.5e7 They rarely occur in infants
and seldom involve the lips.3,4 A review of the literature in
English reveals only four cases of neurothekeomas in
infants, and none is cellular neurothekeoma or involves the
lip.3,12e14 In an infant with a lip tumor that has no skin
change and is asymptomatic as in the case with our patient,
the tumor might be neglected and is difficult to diagnose.
Surgery is another important problem. For lip tumors,
complete tumor excision and cosmetics should be consid-
ered together. Cellular neurothekeomas may have deep
involvement of the subcutis and skeletal muscle when they
are located in the face, and such characteristics might
contribute to tumor recurrence.4 Additionally, tumors on
the face tend to have enhanced recurrent potential
because of a more conservative initial procedure.4 There-
fore, cellular neurothekeomas may recur. Their recurrence
rate was estimated to be 7.5%, as 10 of 133 patients with
cellular neurothekeomas had tumor recurrence after
a mean of 18 months of follow-up, and most recurrent
cellular neurothekeomas are located at the face and have
been marginally excised or had involved excision margins.3
In our patient, we approached the tumor from the mucosal
side of the upper lip to avoid visible scarring. Although the
tumor was totally excised, it extended to the muscular
layer; this patient must be followed up regularly to observe
whether the tumor recurs.
Although the vast majority of oral lesions in infants and
children are benign in character, ranging from 84% to 99% of
cases, malignant tumors should be taken into account, and
most of them are sarcomas.2 Clinically, benign tumors are
usually slow-growing, mobile, and asymptomatic; further-
more, malignant tumors often present as rapidly enlarging
masses and may extend deeply to muscle and fascia.6
Sometimes it is difficult to differentiate between benign
and malignant tumors, and any suspicion of malignancy has
to be taken as an indication to perform histopathological
examination.2 In addition, immunohistochemical and
ultrastructural studies may be necessary for the differential
diagnosis of the oral tumors.13 Most cellular neuro-
thekeomas present as asymptomatic papules or nodules,
with variable consistency, and a mean diameter of 1 cm,
but with rapid growth.7 However, neurothekeomas can
occasionally have atypical features, including large tumor
size (up to 6 cm), deep penetration (extending into skeletal
muscle or subcutaneous fat, or both), diffusely infiltrative
bordered, vascular invasion, high mitotic rate, and
enlarged cytological pleomorphism.14,15 These atypical
features might suggest the potential for malignant trans-
formation of cellular neurothekeomas.3,6,14,15 However,
cellular neurothekeomas with atypical features do not
behave in a low-grade malignant fashion, with rare recur-
rence and absence of metastasis; thus, such atypical
features have been considered to have no clinical signifi-
cance.3 Therefore, it is important to differentiate cellular
neurothekeomas from malignant lesions because the
treatment strategies are different.
In summary, although cellular neurothekeoma rarely
occurs in the lip of an infant, it is important to be aware of
this rare lesion that often causes diagnostic and/or treat-
ment problems.
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